Global Market for Pneumococcal Vaccines (up to 2027): Conjugate Vaccines, Polysaccharide Vaccines
According to the research report by 360iResearch, the global pneumococcal vaccine market size, which was $8,807.48 million in 2021, is expected to grow to $9,573.81 million in 2022 and further expand at an average annual rate of 8.87% to reach $14,672.03 million by 2027. This report is a comprehensive study of the global pneumococcal vaccine market, including an introduction, research methodology, executive summary, market overview, market insights, analysis by type (conjugate vaccines, polysaccharide vaccines), analysis by disease (bronchitis, meningitis, pneumonia, sepsis), analysis by product (Pneumovax 23, Prevnar 13, Synflorix), analysis by distribution (government agencies, non-governmental organizations), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.
Inquire About This Product
basic information
- Introduction - Research Methodology - Executive Summary - Market Overview - Market Insights - Global Pneumococcal Vaccine Market Size: By Type - Market Size of Conjugate Vaccines - Market Size of Polysaccharide Vaccines - Global Pneumococcal Vaccine Market Size: By Disease - Market Size in Bronchitis - Market Size in Meningitis - Market Size in Pneumonia - Market Size in Sepsis - Global Pneumococcal Vaccine Market Size: By Product - Market Size of Pneumovax 23 - Market Size of Prevnar 13 - Market Size of Synflorix - Global Pneumococcal Vaccine Market Size: By Distribution - Market Size of Government Agency Channels - Market Size of Non-Governmental Agency Channels - Global Pneumococcal Vaccine Market Size: By Region - Market Size of Pneumococcal Vaccines in North and South America Market Size of Pneumococcal Vaccines in the United States Market Size of Pneumococcal Vaccines in Canada *For more details → https://www.marketresearch.co.jp/mrc2304f208-pneumococcal-vaccine-market-research-report/
Price range
Delivery Time
P2
Applications/Examples of results
• First, it is necessary: research and development, sales, management planning, product planning, public relations, new business development, patents, purchasing, etc. • Investigate the global market size, market trends, and market forecasts for pneumococcal vaccines. • Investigate the global market size for pneumococcal vaccines by segment: analysis by type (conjugate vaccines, polysaccharide vaccines), analysis by disease (bronchitis, meningitis, pneumonia, sepsis), analysis by product (Pneumovax 23, Prevnar 13, Synflorix), analysis by distribution (government agencies, non-governmental organizations), analysis by region (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, others). • English title: Pneumococcal Vaccine Market Research Report by Type, Indication, Product, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19.
Company information
At Market Research Center Co., Ltd., we partner with global research companies to sell global market research materials and provide commissioned research services. On our website "https://www.marketresearch.co.jp", we handle research materials for various industries such as chemicals, electronics, automotive, industrial equipment, healthcare, biotechnology, agriculture, logistics, construction, aerospace, defense, energy, IT, telecommunications, finance, services, retail, food, and consumer goods. Please utilize the market forecasts and analysis reports offered by Market Research Center for strategic planning, overseas expansion, and the creation of new businesses. For inquiries, please email us at "mr@marketresearch.co.jp".